Charité is one of the largest university hospitals in Europe. All clinical care, research and teaching is delivered by physicians and researchers of the highest international standard. Charité proudly lays claim to more than half of all German Nobel Prize winners in Physiology or Medicine, including Emil von Behring, Robert Koch, and Paul Ehrlich. Charité is internationally renowned for its excellence in teaching and training. Charité – Universitätsmedizin Berlin represents a single medical faculty, which serves both Humboldt Universtität zu Berlin and Freie Universität Berlin. Charité extends over four campuses, and has close to 100 different Departments and Institutes, which make up a total of 17 different Charité Centers. Having marked its 300-year anniversary in 2010, Charité is now one of the largest employers in Berlin, employing 13,100 staff (or 16,800 if including its subsidiaries), and with a total annual turnover of € 1.5 billion.
Charite Universitaetsmedizin Berlin
Chariteplatz 1
10117 BERLIN
Germany
BIOCAPAN contact:
Prof. Dr. Hans Bäumler
Tel : +4930450525131
Email: hans.baeumler@charite.de
The people involved in the project belong to the AG-Bäumler of the Charité-Universitätsmedizin Berlin (see image).
Prof. Dr. Hans Bäumler from Charité-Universitätsmedizin Berlin, habilitation in biophysics (Humboldt University of Berlin), guest-Professor in Paris 7, research visiting professor at the Medical Academy of Science (Russia), University of California (LA) has expertise on biomaterials for tissue engineering, flow properties of blood, cell-cell interactions, drug delivery and nanotechnology. He has published more than 150 peer-reviewed scientific articles in journals like Nanoletters, small, Advanced Materials, ACS Nano, Biomacromolecules etc., 3 book-chapters, and has more than 12 authorized patents. He is also PI at the Berlin-Brandenburg Center of Regenerative Therapies. He will support all partners during the project in GMP and regulatory tasks. A novel oxygen carrier (HbOC) was developed in his department and is currently prepared for clinical trials.
Dr. Radostina Georgieva from Charité-Universitätsmedizin Berlin, Master in Biology and PhD in Biophysics, Humboldt University, Berlin, Germany has expertise in biopolymer particles, RBC loading and functionalization, drug delivery, cell interactions with particles. She has published peer reviewed articles in NanoLetters, ACS Nano, Advanced Functional Materials, Small, Biomaterials, Chemistry of Materials, Biomacromolecules etc., 1 book chapter and 3 patents. She has a long experience with international co-operations and will support the adaptation of HbOC on the needs of islet encapsulation as well as the regulatory tasks.
Dr. Yu Xiong from Charité-Universitätsmedizin Berlin, Master in Pharmacy, University Muenster, Germany, PhD in Pharmacy, Free University, Berlin, Germany, has expertise in fabrication of biopolymer particles and their surface modification, flow cytometry HPLC, confocal microscopy. He has published in Biomacromolecules and Microscopy research and technique.
Kathrin Smuda from Charité-Universitätsmedizin Berlin, Master in Biotechnology, Beuth University of Applied Science, Berlin, Germany is a scientific coworker with expertise in cell culture, RBC loading, membrane functionalization, flow cytometry and confocal microscopy.
